Related Experiment Video
Updated: Dec 24, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure: DRI2P2S
Hannah Rosenblum1, Navin K Kapur2, William T Abraham3
1Division of Cardiology, New York Presbyterian Hospital, New York, NY (H.R., N.U.).
Novel devices offer new hope for acute decompensated heart failure patients when drugs fail. These investigational therapies aim to improve heart function and fluid balance, addressing key issues in heart failure management.
Area of Science:
- Cardiology
- Medical Devices
- Nephrology
Background:
- Acute decompensated heart failure (ADHF) is a leading cause of hospitalization in older adults.
- Pharmacological therapies have shown limited success in improving ADHF outcomes.
- Novel device-based interventions are being developed to address hemodynamic and fluid balance issues in ADHF.
Purpose of the Study:
- To review the pathophysiology and current management of ADHF.
- To describe seven classes of investigational device-based interventions for ADHF.
- To discuss challenges in clinical trial design for these novel devices.
Main Methods:
- Review of existing literature on ADHF pathophysiology and treatments.
- Categorization of novel devices based on their mechanism of action (DRI2P2S acronym).
- Description of device classes including Dilators, Removers, Inotropes, Interstitial devices, Pushers, Pullers, and Selective intrarenal artery catheters.
Main Results:
- Seven distinct classes of investigational devices targeting ADHF pathophysiology are described.
- Devices aim to improve hemodynamics, renal perfusion, and fluid removal.
- Challenges in clinical trial design, patient selection, and endpoint determination are highlighted.
Conclusions:
- Device-based interventions represent a promising new frontier for managing ADHF.
- Careful consideration of trial design is crucial for establishing the efficacy of these novel therapies.
- Further research and clinical trials are needed to validate these device strategies.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Heart Failure Drugs: Diuretics

